Safety and Effectiveness of Experimental IMC-F106C for Advanced PRAME-Positive Cancers
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Immunocore Ltd
- Links
- Sign up for this study
- ID
- NCT04262466
- Phase
- Phase 1/2 Solid Tumor Research Study
- Study Type
- Interventional
- Participants
- Expecting 727 study participants
- Last Updated